Collagenase ( DrugBank: Collagenase )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 162 | Pemphigoid | 1 |
162. Pemphigoid
Clinical trials : 83 / Drugs : 128 - (DrugBank : 51) / Drug target genes : 33 - Drug target pathways : 142
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02202642 (ClinicalTrials.gov) | January 2012 | 21/4/2011 | The Improvement of Limbal Epithelial Culture Technique by Using Collagenase to Isolate Limbal Stem Cells | The Improvement of Limbal Epithelial Culture Technique for the Treatment of Unilateral Limbal Insufficiency by Using Collagenase to Isolate Limbal Stem Cells | Alkaline Chemical Burn Of Cornea And Conjunctival Sac;Acid Chemical Burn Of Cornea And Conjunctival Sac;Benign Mucous Membrane Pemphigoid With Ocular Involvement | Procedure: collagenase | National Taiwan University Hospital | NULL | Recruiting | 18 Years | 70 Years | Both | 10 | Phase 1 | Taiwan |